HUM:NYE-Humana Inc (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 260.57

Change

-6.57 (-2.46)%

Market Cap

N/A

Volume

3.50M

Analyst Target

USD 448.08
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-21 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

+1.86 (+0.33%)

USD 525.99B
ELV Elevance Health Inc

-8.51 (-1.98%)

USD 118.03B
CNC Centene Corp

-1.02 (-1.64%)

USD 32.62B
MOH Molina Healthcare Inc

-3.12 (-1.08%)

USD 16.98B
OSCR Oscar Health Inc

-0.38 (-2.32%)

USD 4.35B
NEUE NeueHealth Inc

+0.05 (+0.91%)

USD 0.05B
CI Cigna Corp

-15.77 (-4.69%)

N/A
CVS CVS Health Corp

-2.17 (-3.60%)

N/A

ETFs Containing HUM

TUSB:CA TD Select U.S. Short Term.. 2.16 % 0.28 %

-0.01 (-1.00%)

CAD 9.58M
TUSB-U:CA TD Select U.S. Short Term.. 2.16 % 0.00 %

N/A

CAD 8.25M
SRHQ Elevation Series Trust - .. 1.84 % 0.00 %

-0.39 (-1.00%)

N/A
CVMC Morgan Stanley ETF Trust .. 0.50 % 0.00 %

-0.61 (-1.00%)

N/A
FUM:CA 0.00 % 0.80 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

-0.79 (-1.00%)

N/A
MUS:CA 0.00 % 0.58 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

-1.30 (-1.00%)

N/A
VETS 0.00 % 0.60 %

N/A

N/A
XSGI:LSE Xtrackers S&P Global Infr.. 0.00 % 0.00 %

-16.50 (-1.00%)

USD 0.27B
XSSX:LSE Xtrackers - Euro Stoxx 50.. 0.00 % 0.00 %

+5.40 (+-1.00%)

USD 0.05B
DXSP:XETRA Xtrackers - Euro Stoxx 50.. 0.00 % 0.00 %

+0.06 (+-1.00%)

USD 0.05B
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
GBLO 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -43.08% 75% C 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -43.08% 75% C 16% F
Trailing 12 Months  
Capital Gain -49.45% 63% D 8% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return -49.45% 63% D 12% F
Trailing 5 Years  
Capital Gain -10.21% 83% B 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.21% 83% B 42% F
Average Annual (5 Year Horizon)  
Capital Gain 2.69% 25% F 47% F
Dividend Return 3.38% 25% F 40% F
Total Return 0.69% 40% F 16% F
Risk Return Profile  
Volatility (Standard Deviation) 19.65% 88% B+ 53% F
Risk Adjusted Return 17.19% 13% F 36% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.